A Genomics-Based Approach to Radically Transform Healthcare

I had the pleasure or speaking with Dr. Ashley Van Zeeland, co-founder and CEO of Cypher Genomics and current CTO of HLI (Human Longevity, Inc.). HLI's goal is to give everyone access to the power of data-driven health intelligence, using multiple data streams to aid in the interpretation of genomic information. We talked about using genomics in the context of phenotypic and clinical data to drive health intelligence, how advances in technology are enabling this analysis, and some of the challenges facing HLI and personalized medicine as a whole. It was a fascinating conversation; listen below, or scroll down to read the transcript.